India, Aug. 29 -- S.V. Krishna Reddy needs no introduction as he is one of the legendary directors in Telugu cinema. No other director in the late 1990s and early 2000s has delivered as many hits as K... Read More
Mumbai, Aug. 29 -- Snowman Logistics will hold a meeting of the Board of Directors of the Company on 25 August 2025. Published by HT Digital Content Services with permission from Capital Market.... Read More
Mumbai, Aug. 29 -- Marc Loire Fashions will hold a meeting of the Board of Directors of the Company on 2 September 2025. Published by HT Digital Content Services with permission from Capital Market.... Read More
France, Aug. 29 -- France and Germany will on Friday discuss a new way of producing weapons in the European Union - the so-called "best athlete" model, where the company most suited to the job builds ... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1031250278) titled 'A study to examine the effects of a new exercise method for people wit... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1030250281) titled 'Long-term outcomes of assertive community treatment in Japan: 7-year f... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2031250283) titled 'A Study to Learn About Medicine Called Ritlecitinib in Children Aged B... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1032250282) titled 'Impact evaluation of doctor-to-doctor telehealth including video commu... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1040250072) titled 'Electrical Current Levels to Elicit Moderate Pain and Concomitant Pupi... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2051250084) titled 'Phase 1 Clinical study of KA-2301' on Aug. 5. Study Type: Interventio... Read More